Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
We examined the interplay between the insulin/IGF-1- and beta-catenin-regulated pathways, both of which are suspected to play a role in hepatocarcinogenesis. Insulin and IGF-1 stimulated the transcription of a Lef/Tcf-dependent luciferase reporter gene by 3-4-fold in HepG2 cells. This stimulation was mediated through the activation of phosphatidylinositol 3-kinase (PI 3-K)/Akt and the inhibition of glycogen synthase kinase-3beta (GSK-3beta) since the effects of insulin and IGF-1 were inhibited by dominant-negative mutants of PI 3-K or Akt and an uninhibitable GSK-3beta. Together with inhibiting GSK-3beta, insulin and IGF-1 increased the cytoplasmic levels of beta-catenin. The PI 3-K/Akt/GSK-3beta pathway was not the sole to mediate insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription. The Ras signalling pathway was also required as (i) the stimulatory effects of insulin and IGF-1 were inhibited by dominant-negative Ras or the MEK1 inhibitor PD98059 and (ii) activated Ha-Ras or constitutively active MEK1 synergized with catalytically inactive GSK-3beta to stimulate Lef/Tcf-dependent transcription. This study provides the first evidence that insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades bifurcating downstream of PI 3-K and involving GSK-3beta inhibition and Ras activation. These findings demonstrate for the first time the ability of insulin and IGF-1 to activate the beta-catenin pathway in hepatoma cells and thereby provide new insights into the role of these factors in hepatocarcinogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cross-talk between the Wnt and insulin signaling pathways has been demonstrated in different disorders such as diabetes and cancer49-53.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [52]
Citations
Cites
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529 · cited 2×
“Results are representative of three independent experiments Oncogene zation in Wnt/Wingless signalling (Aberle et al., 1997), we next wished to examine whether insulin- and IGF-1mediated GSK-3b inhibition a ected the level of bcatenin found in the cytoplasm of HepG2 cells.”
BackgroundA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundMECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,017 · cited 1×
“This pathway plays a critical role in development, proliferation and di erentiation (Wodarz and Nusse, 1998).”
BackgroundBinding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422 · cited 1×
“…molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted…”
BackgroundLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · cited 1×
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundFunctional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., & Birchmeier, W. (1998) · Science · doi:10.1126/science.280.5363.596 · Cited by 1,260 · cited 1×
“…coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system…”
BackgroundIkeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,246 · cited 1×
“…et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system (Aberle et al., 1997).”
BackgroundAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“…adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin…”
BackgroundAssociation of the APC Tumor Suppressor Protein with Catenins
Su, L.-K., Vogelstein, B., & Kinzler, K. W. (1993) · Science · doi:10.1126/science.8259519 · Cited by 1,188 · cited 2×
“…mainly at adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al.,…”
Background
Cited by
Items 301–326 of 326
IRS-1 and SOCS2 are key regulators of insulin-like growth factor signaling in intestinal cancer
Ramocki, N. M. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/3cjy-a678
Nuclear β-Catenin Signaling as a Target for Anticancer Drug Development
Chung, E. J., Bonvini, P., Oh, H. J., Neckers, L., & Trepel, J. B. (2002) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-59259-153-4_5
Crosstalk between Insulin and Wnt Signaling Pathways
Sun, J. (2010) · TSpace (University of Toronto) · Cited by 1
The Role of p21-activated Protein Kinase 1 in Metabolic Homeostasis
Chiang, Y. P. (2014) · TSpace (University of Toronto)
The Role of Transcription Factor 7-Like 2 in Hepatic Glucose Metabolism
Ip, W. (2014) · TSpace (University of Toronto)
HSV-1 Remodels PI3-Kinase/AKT Signaling
Quach, K. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r30s8t · Cited by 1
Targeting bone-microenvironment-tumour cell interactions : IGF-1 receptor kinase inhibitors
Logan, J. G. (2012) · ERA
Austin, K. (2017) · TSpace (University of Toronto)
Mechanisms of sensitization to apoptosis in multiple myeloma.
Hammarberg, A. (2007) · Uppsala University Publications (Uppsala University)
Carollo, P. S. (2019) · theses.fr (ABES) · doi:10.70675/22f0f9b9zab4az49cdz81c4z838df1f983ee · Cited by 1
Ghaffari, M. K., Rafati, A., Karbalaei, N., Haghani, M., Nemati, M., Sefati, N., & Namavar, M. R. (2023) · Research Square · doi:10.21203/rs.3.rs-2875665/v1
Wang, Z., Tao, P.-F., Sun, Y.-Y., Song, X., & Huang, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2964826/v1
Rôle du facteur de transcription ChREBP dans la carcinogenèse hépatique
Benichou, E. (2021) · theses.fr (ABES) · doi:10.70675/74f1767dzf02dz44c4z8fcfz6dd53ae718af · Cited by 1
Guo, Y., Zhang, T., Tang, X., Mao, B., Zhang, Q., Zhao, J., & Cui, S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10830-w
Sun, L., Ji, X., Wang, D., Guan, A., Xiao, Y., Xu, H., 杜顺达, Xu, Y., Zhao, H., Lu, X., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13076592
Khodabandehloo, F., Taleahmad, S., Aflatoonian, R., Rajaei, F., Zandieh, Z., Nassiri‐Asl, M., & Eslaminejad, M. B. (2020) · Figshare · doi:10.6084/m9.figshare.13284988
Sun, L., Ji, X., Wang, D., Guan, A., Xiao, Y., Xu, H., 杜顺达, Xu, Y., Zhao, H., Lü, X., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13076595
Intestinal and skin homeostasis : targeting inflammation and cancer
El‐Jamal, N. (2012) · theses.fr (ABES) · doi:10.70675/19534eecz98c4z48b2z92f6z0eb4d568fe93
Implication de l’IGF-1R dans la différenciation épidermique et le vieillissement
Mainzer, C. (2014) · theses.fr (ABES) · doi:10.70675/36e413a8z5ec6z4d5ez8f59zbe405071ea52
Influence de l’insuline et des lipides sur l’activité de la voie Wnt/β-caténine dans le foie
Cabrae, R. (2014) · theses.fr (ABES) · doi:10.70675/fbd80701z8349z41e6z8d8fz6979f80290cc · Cited by 1
Karnam, A. (2019) · theses.fr (ABES) · doi:10.70675/ae464b4az3b90z42fazb943ze3b07d12e80f
Pyridin-2(1H)one derivatives - a new class of therapeutics for trigeminal pain
Murail, P. (2024) · theses.fr (ABES) · doi:10.70675/ad8d129azce02z4a4dz9aa8zea61b5651e61
Christiansen, L., Ragab, M., Nickel, L., Sünderhauf, A., Jegodzinski, L., Hicken, M., Schlichting, H., Weikamp, R., Schmelter, F., Margis, D., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09240-9
Metadata
- Authors
- Desbois-Mouthon, C., Cadoret, A., Blivet-Van Eggelpoël, M.-J., Bertrand, F., Cherqui, G., Perret, C., & Capeau, J.
- Affiliations
- Inserm (FR)
- Venue
- Oncogene
- Published
- 2001-01-11
- Volume
- 20
- Issue
- 2
- Pages
- 252-259
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2069349104
- Cited by
- 321
- References
- 51
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 11 · 2020: 15 · 2019: 14 · 2018: 11 · 2017: 12 · 2016: 5 · 2015: 11 · 2014: 13 · 2013: 25 · 2012: 16
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- insulin, insulin-like growth factor I, β-catenin signaling, GSK-3β inhibition, Ras signaling, PI3K/Akt signaling, MEK1, hepatocarcinogenesis, hepatoma cells, signal transduction
- MeSH terms
- Cell Division, Cytoskeletal Proteins, DNA-Binding Proteins, Enzyme Activation, Enzyme Inhibitors, Flavonoids, Carcinoma, Hepatocellular, Humans, Insulin, Insulin-Like Growth Factor I, Mutation, Proto-Oncogene Proteins, Genes, ras, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Genes, Reporter, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, Glycogen Synthase Kinases, Glycogen Synthase Kinase 3, MAP Kinase Kinase 1, Proto-Oncogene Proteins c-akt, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.